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Century.” 
The self is a legal construct that operates under a civil social contract. 
We have personhood as an artifact of that contract and the expectation 
of obedience to the rule of law. You cannot sell your eye. You can use 
your body for sex but cannot sell your body for sex. You can give and 
sell blood but not most other organs. There is a national shortage of or-
gans available for transplantation, but monetary compensation to do-
nors is banned everywhere except in Iran.  
 And yet there is legal precedence for the body as commodity, be-
ginning with Hawkins v. McGee (1929). Curiously absent from Kara 
Swanson’s monograph, Hawkins (known in casebooks as the “Hairy 
Hand Case”) is one of the first disputes law students encounter. It is 
about how the body has property and value. George Hawkins’s arrange-
ment with his doctor for a restored “perfect” hand is little more than a 
bargain to replace a broken mechanism. (As the casebook title implies, 
he didn’t get what was promised.) 
 Selling two kidneys is a death wish. But the value of the body is not 
depreciated by production of blood, milk, or sperm. Humans aren’t just 
collections of parts; they are general-purpose bodies for the potential 
production of goods and services, or, as Swanson asserts, factories that 
stamp parts for later use. Do individuals, she wants to know, own those 
factories? Would it be better if we considered outputs as gifts or saleable 
commodities? Are they products or services? 
 Swanson explores these tensions through the complex interdiscipli-
nary lens of the history of American medicine and law and the metaphor 
of “banked” inventories of life-sustaining human fluids. The banking 
metaphor, an invention of Chicago physician Bernard Fantus, encour-
aged donors and recipients to think about blood supply as existing in 
dynamic equilibrium, where deposits and withdrawals are managed 
like Keynesian economic theory. It encouraged people to bank ahead 
for a surgical rainy day but also to run deficits and borrow from family 
and friends (“replacement donors”).  
 The banking metaphor, Swanson shows, came under attack in the 
middle decades of the twentieth century. Mass appeals to emotion and 
patriotism, which inspired gifts of blood to the Red Cross during World 
War II and the Cold War, undermined free markets. The powerful 
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American Medical Association (AMA) considered such selfless gener-
osity a form of socialized medicine. The alternative—a for-profit, indi-
vidual “professional donor”—suggested the need for a medical author-
ity. The AMA wanted to replace locally controlled banks—which they 
viewed as interlopers—with medical supervision. Finally, state courts 
began asserting that patients harmed by “bad blood”—infected, for ex-
ample, by hepatitis—might be permitted to plead strict liability under 
product liability law. Such reasoning triggered a reaction against banked 
blood as a commodity. State blood shield laws recast the bank as a fi-
nancial service. 
 Hepatitis (and eventually HIV) screening, scandals involving ex-
pired blood, and the miscegenation bombast of civil rights opponents 
who feared blood purchased from racial minorities all played havoc 
with shield law. By the 1970s, public stereotypes marked gift blood 
as pure blood and bought blood as contaminated. Public confidence 
drained away, stemmed only by President Nixon’s unveiling in 1973 of 
a Federal Blood Policy, which promoted a paradox familiar to students 
of college football: unpaid donor-producers and a network of distribu-
tors and surgical team-captains reimbursed profitably by insurers.  
 Swanson devotes fewer pages to the history of human milk and 
sperm supply chains, largely because they represented much less contro-
versial industries. While the banking metaphor applied to breast milk, 
the AMA refrained from asserting market control. The reasons for this 
included its feminine and intimate expression, easy preservation and 
stockpiling, and the popularity of formula. Sperm banking, pioneered 
by University of Iowa graduate student Jerome Sherman and urology 
professor Raymond Bunge in the 1950s, required “donor differentia-
tion” (199) so that the offspring of assisted reproduction interventions 
shared physiognomies with adoptive fathers. A better analogy, Swanson 
concludes, is the safe deposit box. 
 Swanson suggests that body products be reinterpreted as “civic 
property” in a pluralistic Kingdom of Ends. This is important because 
in the twentieth century bodies were voraciously commoditized for use 
by those artificial persons called corporations. Natural persons were left 
to live with the incongruent wreckage: Moore v. University of California 
(1990), rejecting the claim that people have a property interest in their 
own body parts; Kane v. Hecht (1995) validating the custody of frozen 
sperm willed by lover to girlfriend over the objection of the lover’s par-
ents; and tax courts upholding claims on business expenses related to 
the sale of rare AB blood.  
 
 
